ClinicalTrials.gg
CompletedNCT03280472Updated Oct 13, 2026

Transition to College/Miami University

An interventional study of Cognitive Bias Modification and Symptom tracking in Interpretation Bias Modification and Symptom Tracking, sponsored by Miami University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Miami University · Not applicable, Interventional, and Treatment

Updated Oct 13, 2026Now CompletedEnrollment updatedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The current project will test whether a computerized training program, Cognitive Bias Modification (CBM), can be used as a prevention inoculation tool to reduce vulnerability to anxiety among incoming college students. Those not in the CBM condition will complete a symptom tracking condition (ST). We will also test whether ST influences vulnerability to anxiety among incoming college students.

02

Conditions studied

  • Interpretation Bias Modification
  • Symptom Tracking

Keywords

  • Interpretation Bias
  • Interpretation Modification Program
03

In context

Lead sponsor

Miami University is the lead sponsor of 12 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • First and Second year students
  • Entered college in fall of 2017
  • Fluent in English
  • LSAS-SR score greater than or equal to 14 and less than or equal to 74.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
86 participants (actual)

Study arms

  • Experimental
    Cognitive Bias Modification

    Participants will complete three session of cognitive bias modification.

    Behavioral: Cognitive Bias Modification

  • Other
    Symptom Tracking

    Participants will track their symptoms.

    Behavioral: Symptom tracking

Interventions

  • BehavioralCognitive Bias Modification

    CBM training. For those in the CBM condition, participants will complete a task. In this task, they will read ambiguous, two- to four-sentence social-related scenarios on the computer. The final word in the scenario will have a missing letter. Participants will type the missing letter. Participants will also be asked to answer a "Yes/No" comprehension question about the scenario. The missing letter will "resolve" the ambiguity of the scenario in a positive way, intended to train participants to have more positively-biased interpretations of ambiguous social information

  • BehavioralSymptom tracking

    Participants will track their symptoms

06

What researchers measure

Primary outcomes

  1. Change in Student Adjustment to College Questionnaire

    Self-report on the degree to which the participant feels they are transitioning to college successfully.

    Time frame: Participants report on their past few days. The SACQ is administered at T1-T5. T2 occurs within ~1 week of T1/baseline. T2-T5 are spaced ~1 week apart from each other. Sessions are ~60-90 minutes.

Secondary outcomes

  1. Change in Interpretations

    A questionnaire assessing their interpretation of ambiguous, potentially anxiety-provoking situation

    Time frame: Participants report interpretations to a variety of situations. The IQ is administered at T1 and T4. T2 occurs within 1 week of T1/baseline. T2-T5 are spaced ~1 week apart from each other. Sessions are ~60-90 minutes.

  2. Change in Liebowitz Social Anxiety Scale-Self-Report

    Self-report of social anxiety symptoms

    Time frame: Participants report on symptoms during the past week. The LSAS-SR is administered at T1-T5. T2 occurs within ~1 week of T1/baseline. T2-T5 are spaced ~1 week apart from each other. Sessions are ~60-90 minutes.

07

Study locations

1 site
  • Anxiety Cognition and Emotion Laboratory
    Oxford, Ohio 45056, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2017 to primary completion in Jan 2019, 16 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 30, 2017
First posted
Sep 12, 2017
StartActual
Sep 18, 2017
Primary completionActual
Jan 31, 2019
CompletionActual
Jan 31, 2019
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Status unknown→Completed
changed Oct 13, 2026
Enrollment
60 (estimated)→86 (actual)
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Status unknown→Completed
    Enrollment 60 (estimated)→86 (actual)
    + 4 other changes: date precision, responsible party, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT03280472
Lead sponsor
Miami University
Responsible party
Sponsor
First posted
Sep 12, 2017
Start date
Sep 18, 2017
Primary completion
Jan 31, 2019
Completion
Jan 31, 2019
Last update
Oct 13, 2026

Study contacts

Elise Clerkin, PhD
principal investigator · Miami University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion